Zhangzhou Pientzehuang Pharmaceutical | 600436 - Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
Akebia Therapeutics USD 23.53M 3.19M 2025-12
Alaunos Therapeutics USD 424K 23K 2026-06
Avita Medical AUD 19.54M 516K 2026-06
Cspc Pharmaceutical CNY 1.87B 95.62M 2025-12
Dianthus Therapeutics USD 13.56M 1.09M 2026-06
Ionis Pharmaceuticals USD 154M 23.92M 2026-09
IQVIA Holdings USD 569M 5M 2026-09
Jiangsu Hengrui CNY 2.93B 143.13M 2026-09
Kangmei Pharma CNY 253.72M 16.66M 2026-06
Moderna USD 282M 66M 2026-09
Revvity USD 275.33M 3.25M 2026-09
Sh Fosun Pharma CNY 3.07B 276.55M 2026-09
Tectonic Therapeutic USD 6.17M 260K 2026-06
Viatris USD 950.8M 183.7M 2026-09
Wuxi Apptec CNY 1.25B 263.98M 2026-09
Xeris Pharmaceuticals USD 61.04M 7.89M 2026-06
Zz Pientze Pharmaceu CNY 267.85M 44.71M 2026-09